Expression of serum microRNA 30e-5p in type 2 diabetic patients with diabetic kidney disease
The Egyptian journal of Immunology · 2025
DOI: 10.55133/eji.320401 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Egyptian journal of Immunology, 2025. Verfasst von Raghda E Ibrahim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Chemical Pathology, Faculty of Medicine, Beni-Suef University, , Beni-Suef, Egypt. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Nephropathies, MicroRNAs.
Abstract (Originalsprache)
Type 2 diabetes (T2DM) is the most prevalent form of diabetes, and frequently associated with diabetic nephropathy, a leading contributor to chronic kidney disease (CKD). The presence of microalbuminuria serves as an early marker for diabetic kidney disease (DKD). Emerging evidence suggested that alterations in microRNA (miRNA) 30e-5p expression may be linked to T2DM progression, positioning it as a potential biomarker. This study investigated the clinical relevance of miRNA 30e-5p dysregulation by assessing its expression levels in T2DM patients with and without DKD. A total of 50 participants, including 25 T2DM patients with DKD and 25 T2DM patients without DKD, were examined. Serum miRNA 30e-5p levels were quantified using real-time polymerase chain reaction. Findings revealed a significant reduction in miRNA 30e-5p expression among patients with DKD compared to those without DKD (0.25 ± 0.26 vs. 0.89 ± 0.13, p < 0.001). In conclusion, miRNA 30e-5p dysregulation appears to contribute to DKD development in Egyptian T2DM patients, suggesting its potential as a prognostic biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Chemical Pathology, Faculty of Medicine, Beni-Suef University, , Beni-Suef, Egypt.
- Department of Internal Medicine, Faculty of Medicine, Beni-Suef University, , Beni-Suef, Egypt.
Zitieren
APA
Ibrahim, R. E., Khalil, S. O. A., Abougabal, K., Rabea, A. M., & Abdel-Aziz, M. M. (2025). Expression of serum microRNA 30e-5p in type 2 diabetic patients with diabetic kidney disease. The Egyptian journal of Immunology. https://doi.org/10.55133/eji.320401
Vancouver
Ibrahim RE, Khalil SOA, Abougabal K, Rabea AM, Abdel-Aziz MM. Expression of serum microRNA 30e-5p in type 2 diabetic patients with diabetic kidney disease. The Egyptian journal of Immunology. 2025. doi:10.55133/eji.320401
BibTeX
@article{Ibrahim2025,
author = {Ibrahim, Raghda E and Khalil, Shymaa O A and Abougabal, Khadiga and Rabea, Alaa M and Abdel-Aziz, Manar M},
title = {Expression of serum microRNA 30e-5p in type 2 diabetic patients with diabetic kidney disease},
journal = {The Egyptian journal of Immunology},
year = {2025},
doi = {10.55133/eji.320401}
}
EUVIMED